Kanungo Institute Of Diabetes Specialities Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 3.64 Cr
as on 18-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.95 Cr
as on 18-12-2024
- Satisfied Charges ₹ 8.90 Cr
as on 18-12-2024
- Revenue 9.29%
(FY 2022)
- Profit 996.00%
(FY 2022)
- Ebitda 60.16%
(FY 2022)
- Net Worth 49.64%
(FY 2022)
- Total Assets -1.76%
(FY 2022)
About Kanungo Institute Of Diabetes Specialities
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.64 Cr.
The company currently has active open charges totaling ₹5.95 Cr. The company has closed loans amounting to ₹8.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Alok Kanungo and Mamata Tripathi serve as directors at the Company.
- CIN/LLPIN
U73100OR2005PTC008267
- Company No.
008267
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kanungo Institute Of Diabetes Specialities Private Limited offer?
Kanungo Institute Of Diabetes Specialities Private Limited offers a wide range of products and services, including Graduation & High Education Programs, Career Consultants.
Who are the key members and board of directors at Kanungo Institute Of Diabetes Specialities?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Kanungo  | Managing Director | 22-Jul-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mamata Tripathi | Director | 22-Jul-2005 | Current |
Financial Performance and Corporate Structure Insights of Kanungo Institute Of Diabetes Specialities.
Kanungo Institute Of Diabetes Specialities Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.29% increase. The company also saw a substantial improvement in profitability, with a 996% increase in profit. The company's net worth Soared by an impressive increase of 49.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanungo Institute Of Diabetes Specialities?
In 2022, Kanungo Institute Of Diabetes Specialities had a public holding of 3.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ayan Consultancy Private LimitedActive 15 years 7 monthsAlok Kanungo and Mamata Tripathi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 26 Mar 2015 | ₹4.00 Cr | Open |
Jain Sons Finlease Limited Creation Date: 16 Oct 2013 | ₹1.95 Cr | Open |
State Bank Of India Creation Date: 04 Jun 2007 | ₹8.90 Cr | Satisfied |
How Many Employees Work at Kanungo Institute Of Diabetes Specialities?
Kanungo Institute Of Diabetes Specialities has a workforce of 32 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanungo Institute Of Diabetes Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanungo Institute Of Diabetes Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
